Bronchial artery Embolization for Non-massive and Clinically-stable Hemoptysis patients (BENCH): Randomized Controlled Trial
Not Applicable
Withdrawn
- Conditions
- Symptoms, signs and abnormal clinical and laboratory findings, NEC
- Registration Number
- KCT0005227
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- All
- Target Recruitment
- 116
Inclusion Criteria
a. Age >= 19
b. hemoptysis amount =< 200cc/24hr
c. Stable vital sign
- heart rate < 100 beats/min
- Systolic blood pressure > 90 mmHg
- Respiratory rate < 24 breaths/min
- SpO2 > 90%
d. No history of intervention or surgery within 3 years to control hemoptysis
e. bronchial artery hypertrophy on CT
f. Benign lung parenchymal disease (e.g., tuberculosis, bronchiectasis) on CT
Exclusion Criteria
a.Patients with anticoagulation / antiplatelet agents
b.Coagulopathy (INR>1.5) or thrombocytopenia (Platelet count <50K)
c.Pregnant or lactating women
d.Malignant neoplasms in the lung and bronchus
e.Traumatic hemoptysis
f.Iatrogenic hemoptysis
g.Pulmonary artery thromboembolism
h.Vasculitis
i.Contraindication to tranexamic acid
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 6-month hemoptysis-free rate
- Secondary Outcome Measures
Name Time Method hemoptysis of cessation after treatment;duration;Serious adverse event